Back to Journals » Drug Design, Development and Therapy
Drug Design, Development and Therapy
ISSN: 1177-8881
An international, peer-reviewed, open access journal that spans the spectrum of drug design and development through to clinical applications. The journal is characterized by the rapid reporting of application notes, reviews, original research and clinical studies in all therapeutic areas. Clinical outcomes, patient safety, and programs for the development and effective, safe, and sustained use of medicines will be a feature of the journal.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (4138)
- Volume 18, 2024 (99)
- Volume 17, 2023 (283)
- Volume 16, 2022 (316)
- Volume 15, 2021 (399)
- Volume 14, 2020 (477)
- Volume 13, 2019 (387)
- Volume 12, 2018 (382)
- Volume 11, 2017 (330)
- Volume 10, 2016 (374)
- Volume 9, 2015 (543)
- Volume 8, 2014 (231)
- Volume 7, 2013 (143)
- Volume 6, 2012 (42)
- Volume 5, 2011 (40)
- Volume 4, 2010 (35)
- Volume 3, 2009 (27)
- Volume 2, 2008 (29)
- Volume 1, 2007 (1)
Latest articles:
- 5 records -
Network and Experimental Pharmacology on Mechanism of Yixintai Regulates the TMAO/PKC/NF-κB Signaling Pathway in Treating Heart Failure
Wang Z, Liu C, Wei J, Yuan H, Shi M, Zhang F, Zeng Q, Huang A, Du L, Li Y, Guo Z
Drug Design, Development and Therapy 2024, 18:1415-1438
Published Date: 30 April 2024
The Molecular Biological Mechanism of Hydrogen Therapy and Its Application in Spinal Cord Injury
Hu Q, Li Y, Lin Z, Zhang H, Chen H, Chao C, Zhao C
Drug Design, Development and Therapy 2024, 18:1399-1414
Published Date: 29 April 2024
Research Progress of Long Non-Coding RNA in Tumor Drug Resistance: A New Paradigm
Zhang J, Wu L, Wang C, Xie X, Han Y
Drug Design, Development and Therapy 2024, 18:1385-1398
Published Date: 26 April 2024
Dynasore Alleviates LPS-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis
Shan M, Wan H, Ran L, Ye J, Xie W, Lu J, Hu X, Deng S, Zhang W, Chen M, Wang F, Guo Z
Drug Design, Development and Therapy 2024, 18:1369-1384
Published Date: 23 April 2024
Propofol and Dexmedetomidine Ameliorate Endotoxemia-Associated Encephalopathy via Inhibiting Ferroptosis
Zhou Y, Yang Y, Yi L, Pan M, Tang W, Duan H
Drug Design, Development and Therapy 2024, 18:1349-1368
Published Date: 23 April 2024